company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10995000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,56000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,52211000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1010000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,26000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1545000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,65843000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1869000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,141000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,603000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,744000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,,totalassets,Total Assets,=,debit,usd,68456000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,474000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3026000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9137000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6426000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19063000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8978000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,10673000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19651000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,38714000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,169902000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-140172000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,12000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,29742000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,29742000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,29742000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,,2011-06-30,2011-08-12 17:04:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,68456000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17299000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,38031000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1650000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,53000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,997000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,58030000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1831000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,197000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,550000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,747000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,,totalassets,Total Assets,=,debit,usd,60608000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1228000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3369000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8559000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4549000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17705000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8340000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7666000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16006000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33711000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,171469000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-144575000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,26897000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,26897000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,26897000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,,2011-09-30,2011-11-14 16:00:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,60608000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13240000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,44714000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1966000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,845000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,60765000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1677000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,197000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,791000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,988000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,,totalassets,Total Assets,=,debit,usd,63430000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5045000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5610000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9036000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3917000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23608000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,12493000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6651000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19144000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42752000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,194133000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-173451000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,20678000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,20678000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,20678000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,,2012-03-31,2012-05-10 16:39:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,63430000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,4950000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,36022000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1583000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1941000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,44496000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1626000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,197000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,31000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,228000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,,totalassets,Total Assets,=,debit,usd,46350000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5166000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3549000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9449000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3582000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21746000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,11720000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6133000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17853000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,39599000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,195047000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-188291000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6751000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6751000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6751000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,,2012-06-30,2012-08-09 16:10:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,46350000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14576000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,22052000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1701000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2743000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,41072000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1535000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,197000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,33000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,230000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,,totalassets,Total Assets,=,debit,usd,42837000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9167000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3299000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9462000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3279000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,25207000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,18205000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5614000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,23819000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49026000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,196545000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-202735000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-6189000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-6189000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-6189000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,,2012-09-30,2012-11-09 16:21:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,42837000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11547000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,20829000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,580000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2524000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,35480000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1402000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,197000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,299000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,496000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,,totalassets,Total Assets,=,debit,usd,37378000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10139000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4609000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10050000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1222000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,26020000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,13377000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5956000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19333000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,45353000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,222309000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-230289000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-7975000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-7975000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-7975000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,,2013-03-31,2013-05-10 16:07:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,37378000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7315000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1698000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,38507000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1470000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2552000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,51542000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,543000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4134000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,,totalassets,Total Assets,=,debit,usd,56971000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4800000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8299000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2361000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15460000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,27714000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6388000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,34102000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49562000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,246848000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-244385000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2457000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2457000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2457000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,,2013-06-30,2013-08-09 16:52:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,56971000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6075000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1240000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,28609000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1761000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1875000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,39560000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1217000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3412000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,692000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4104000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,,totalassets,Total Assets,=,debit,usd,44881000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5109000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10706000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6777000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22592000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,27922000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1636000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29558000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,52150000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,248966000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-261194000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,7000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-12221000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-12221000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-12221000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,,2013-09-30,2013-11-08 16:40:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,44881000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14792000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1111000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,117269000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,2677000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4074000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,139923000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1512000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,13565000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1921000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,15486000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,,totalassets,Total Assets,=,debit,usd,156921000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1763000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6847000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9017000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,823000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18450000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,26470000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1358000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,27828000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,46278000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,257288000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-151618000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,21000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,105691000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,105691000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,105691000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,,2014-03-31,2014-05-12 17:00:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,156921000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,19962000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1294000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,106445000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,856000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2770000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,131327000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1588000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2831000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1885000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4716000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,,totalassets,Total Assets,=,debit,usd,137631000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4479000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5224000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12349000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,790000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22842000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,23972000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1215000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25187000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48029000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,260735000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-176126000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,41000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,84650000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,84650000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,84650000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,,2014-06-30,2014-08-11 06:05:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,137631000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,16858000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1071000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,124021000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,2012000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1366000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4234000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,149562000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1712000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,6986000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,373000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7359000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,,totalassets,Total Assets,=,debit,usd,158633000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4091000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15831000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4377000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24299000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,28646000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37287000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,65933000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,90232000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,270888000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-207468000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,29000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,63449000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,63449000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,63449000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,,2014-09-30,2014-11-07 16:59:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,158633000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22060000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,548000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,152798000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,3255000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2302000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5314000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,186277000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1590000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,24164000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2857000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,27021000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,,totalassets,Total Assets,=,debit,usd,214888000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3655000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16249000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,19518000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1269000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,40691000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,60808000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,35028000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,818000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,96654000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,137345000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,303129000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-230553000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,72591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,72591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,72591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,,2015-03-31,2015-05-08 16:37:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,214888000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7490000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,159857000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,5869000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3181000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5261000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,181805000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1731000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9391000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2851000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12242000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,,totalassets,Total Assets,=,debit,usd,195778000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4506000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19219000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4150000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1282000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,29157000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,61664000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34005000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,722000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,96391000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,125548000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,309040000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-243749000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-13000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,65278000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,65278000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,65278000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,,2015-06-30,2015-08-07 16:12:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,195778000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10209000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,927000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,139032000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,22958000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3454000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4176000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,180756000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1732000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3246000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2745000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5991000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,,totalassets,Total Assets,=,debit,usd,188479000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8048000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18027000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4235000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,31605000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,62298000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,33225000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,627000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,96150000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,127755000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,4952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,315673000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-259926000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,55772000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,55772000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,55772000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,,2015-09-30,2015-11-06 16:08:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,188479000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24972000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,148000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,110646000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,14946000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2678000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3908000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,157298000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2323000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2094000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2287000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4381000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,,totalassets,Total Assets,=,debit,usd,164002000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3672000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17398000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3546000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,396000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,25012000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,62255000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,31667000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,435000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,94357000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,119369000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,49000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,339402000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-294987000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,169000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44584000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44584000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44584000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,,2016-03-31,2016-05-10 16:12:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,164002000.0
